Michigan is expected to get nearly $3.4 million of a multi-state settlement with a pharmaceutical company. Attorney General Bill Schuette says in a statement Friday that the money ispart of a $125 million national settlement with Cephalon. Part of the money will go to Michigan consumers who bought the drug Provigil. The settlement ends a multistate investigation into conduct by Cephalon that delayed generic versions of Provigil from entering the market for years, causing consumers to pay higher prices. The company denied wrongdoing. The settlement is subject to court review.